Prescription dermatology medicines for moderate-to-severe skin conditions.

Galderma
Galderma is a dermatology-focused company whose brands include Cetaphil, spanning consumer skincare and prescription dermatology.
- 8.9k
- Public
- Zug, CH
Galderma is a dermatology-focused company that researches, develops, and commercializes products across consumer skincare and prescription dermatology. Its brand portfolio includes Cetaphil, a sensitive-skincare line positioned for sensitive skin and sold in more than 70 countries.
The company's activities span daily skincare and treatments for a range of skin conditions, with brands covering cleansers, moisturizers, and dermatological therapies. Galderma operates globally and has been listed on the SIX Swiss Exchange since 2024.
Products & Services
Similar Companies

Cetaphil

3SBio

Legend Biotech

Iovance Biotherapeutics

Medpace
Active Biotech
Starfield Food & Science Technology

AbbVie
abbvie.com

Incyte
incyte.com

Sanofi
sanofi.com

Kenvue
kenvue.com

L'Oreal
loreal.com
CeraVe
cerave.com

Cristália
cristalia.com.br

Evolus
evolus.com

Revance Therapeutics
revance.com

Merz Aesthetics
merzaesthetics.com
Quick Facts
Who are Galderma's competitors?
Companies similar to Galderma include AbbVie, Incyte, Sanofi and Kenvue.
When was Galderma founded?
Galderma was founded in 1981.
When was Galderma's last funding round?
Galderma's most recent funding round was for CHF2.3B (CHF) in March 2024.
How much disclosed funding has Galderma raised?
As of Mar 21, 2024, Galderma has disclosed funding of CHF2.3B (CHF). Undisclosed round amounts are excluded.
How many employees does Galderma have?
Galderma has 8,941 employees as of Sep 12, 2026.
Classification
- Industry
- Ownership
- Geographic Exposure
- Model
- Revenue
- Ticker
- GALD